Moderna requests emergency use authorization for COVID-19 vaccine in young kids
Moderna requests emergency use authorization from the FDA for its vaccine for children as young as six-months-old.
The FDA said Friday it plans to convene its outside panel of vaccine experts on June 8, 21 and 22 to review applications from Moderna and Pfizer for vaccines in tots and babies. The dates are tentative and regulators said they will provide more details later.
Moderna requests emergency use authorization from the FDA for its vaccine for children as young as six-months-old.
Consumer News: Reports of people getting sick after eating Lucky Charms, ways to save on your vacation and more
The U.S. Food and Drug Administration is investigating Lucky Charms cereal after dozens of consumers complained of illness after eating it.
Health care providers hoping to get new guidance on coronavirus vaccines from the FDA will have to keep waiting. Wednesday’s meeting ended with no solid answers regarding the future of booster shots and regular vaccines.
U.S. regulators are allowing people 50 and older to get another booster dose of the Pfizer or Moderna COVID-19 vaccine.
On the vaccine front, an official with the FDA is suggesting a fourth dose of the COVID-19 vaccine might be needed closer to fall.
Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness.
In the midst of the surge of COVID cases the FDA is now allowing Pfizer booster shots for children as young as 12 years old.
The Food and Drug Administration on Monday allowed extra Pfizer shots for children as young as 12. Boosters already are recommended for everyone 16 and older, and the FDA says they’re also warranted for 12- to 15-year-olds.